Kite Pharma, Inc.
SANTA MONICA, CA · Founded 2009 · CIK 0001510580 · Biotech · Acquired
Genetically engineered CAR-T cell therapies for cancer treatment
kitepharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $79M
- 4 Form D · May 2014
- 149 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 16 granted · 24 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20102011201220132014
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $12,453,375 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $16,420,598 | |
| Private capital raised | Form D · SEC | $50,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2853 | EMPHYMAB BIOTECH, LLC | — | — |
| 2854 | KSQ Therapeutics | — | $81M |
| 2855 | Varigen Biosciences Corporation | — | — |
| 2856 | Kite Pharma, Inc. | — | $79M |
| 2857 | Eyedesis Biosciences, LLC | — | — |
| 2858 | ZYMOSENSE INC. | — | — |
| 2859 | KERACEUTICALS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Arie BelldegrunDirector · Executive Officer
- Marc BetterExecutive Officer
- David BondermanDirector
- Cynthia ButittaExecutive Officer
- Farah ChampsiDirector
- Roy DoumaniDirector
- Aya JakobovitsDirector · Executive Officer
- Joshua KazamDirector
- Gloria LeeExecutive Officer
- Keith NolopExecutive Officer
- Ran NussbaumDirector
- Jonathan PeacockDirector
- Margo RobertsExecutive Officer
- Steven RuchefskyDirector
- Rizwana SprouleExecutive Officer
Patents
- Gene Editing Combinations For Allogeneic Car-t Cells With Enhanced Immune Evasionapplication
- Systems And Methods For Detecting Suspended Particles In Fluidsgranted
- Chimeric Antigen Receptors And Cell Therapies For Autoimmune Diseasesapplication
- Cassette Rackgranted
- Methods Of Administering Chimeric Antigen Receptor Immunotherapygranted
- GPC3 Binding Moleculesapplication
- Methods Of Administering Chimeric Antigen Receptor Immunotherapygranted
- Biomarkers Related To Immunotherapy Efficacyapplication
- Systems And Methods For Shipping Cryogenically-frozen Materialsapplication
- High-throughput Manufacturing And Screening Of Car-t Cellsapplication
- Sealing Systems For Use With Product Bags Used In Cryogenic Freezing And Methods Of Useapplication
- Chimeric Antigen Receptor T Cell Therapygranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.